EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention

Awad I Javaid iD, Joel E Michalek, Aleksandra B Gruslova iD, Serene A Hoskins, Chowdhury H Ahsan, Marc D Feldman

Catheterization and Cardiovascular Interventions · 2024-01 · 103 (1) · 30-41

DOI: 10.1002/ccd.30913 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, published online on 2023-11-23. Written by Awad I Javaid and 5 co-authors. Institution: Division of Cardiovascular Medicine, Kirk Kerkorian School of Medicine at the University of Nevada Las Vegas, Las Vegas, Nevada, USA. Major MEDLINE topics: Percutaneous Coronary Intervention, Myocardial Infarction, Heart-Assist Devices. Cited 7 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Previous studies have compared Impella use to intra‐aortic balloon pump (IABP) use in patients with acute myocardial infarction and cardiogenic shock (AMI‐CS) undergoing percutaneous coronary intervention (PCI). Our objective was to compare clinical outcomes in patients with AMI‐CS undergoing PCI who received Impella (percutaneous left ventricular assist device) without vasopressors, IABP without vasopressors, and vasopressors without mechanical circulatory support (MCS).

Methods

We queried the National Inpatient Sample (NIS) using ICD‐10 codes (2015–2018) to identify patients with AMI‐CS undergoing PCI. We created three propensity‐matched cohorts to examine clinical outcomes in patients receiving Impella versus IABP, Impella versus vasopressors without MCS, and IABP versus vasopressors without MCS.

Results

Among 17,762 patients, Impella use was associated with significantly higher in‐hospital major bleeding (31.4% vs. 13.6%; p < 0.001) and hospital charges ( p < 0.001) compared to IABP use, with no benefit in mortality (34.1% vs. 26.9%; p = 0.06). Impella use was associated with significantly higher mortality (42.3% vs. 35.7%; p = 0.02), major bleeding (33.9% vs. 22.7%; p = 0.001), and hospital charges ( p < 0.001), when compared to the use of vasopressors without MCS. There were no significant differences in clinical outcomes between IABP use and the use of vasopressor without MCS.

Conclusions

In this analysis of retrospective data of patients with AMI‐CS undergoing PCI, Impella use was associated with higher mortality, major bleeding, and in‐hospital charges when compared to vasopressor therapy without MCS. When compared to IABP use, Impella was associated with no mortality benefit, along with higher major bleeding events and in‐hospital charges. A vasopressor‐only strategy suggested no difference in clinical outcomes when compared to IABP. This study uses the NIS for the first time to highlight outcomes in AMI‐CS patients undergoing PCI when treated with vasopressor support without MCS, compared to Impella and IABP use.

Subjects

MeSH terms (MEDLINE)

Percutaneous Coronary InterventionMyocardial InfarctionHeart-Assist DevicesHumansShock, CardiogenicRetrospective StudiesTreatment OutcomeIntra-Aortic Balloon PumpingHemorrhage

Author keywords

ACS-acute coronary syndromeCS-cardiogenic shockImpellaMCS-mechanical circulatory supportPCI-percutaneous coronary intervention

Authors and institutions

  • Division of Cardiovascular Medicine, Kirk Kerkorian School of Medicine at the University of Nevada Las Vegas, Las Vegas, Nevada, USA.
  • Department of Population Health Sciences, The University of Texas Health at San Antonio, San Antonio, Texas, USA.
  • Division of Cardiology, Department of Medicine, The University of Texas Health at San Antonio, San Antonio, Texas, USA.

ORCID profiles: Awad I Javaid, Aleksandra B Gruslova

Cite

APA

Javaid, A. I., Michalek, J. E., Gruslova, A. B., Hoskins, S. A., Ahsan, C. H., & Feldman, M. D. (2024). Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions, 103(1), 30-41. https://doi.org/10.1002/ccd.30913

Vancouver

Javaid AI, Michalek JE, Gruslova AB, Hoskins SA, Ahsan CH, Feldman MD. Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. 2024;103(1):30-41. doi:10.1002/ccd.30913

BibTeX
@article{Javaid2024,
  author = {Javaid, Awad I and Michalek, Joel E and Gruslova, Aleksandra B and Hoskins, Serene A and Ahsan, Chowdhury H and Feldman, Marc D},
  title = {Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  volume = {103},
  number = {1},
  pages = {30--41},
  doi = {10.1002/ccd.30913}
}
Start for free →